Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K C Marsh

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Journal of Medicinal Chemistry|January 19, 1996
A novel, picomolar inhibitor of human immunodeficiency virus type 1 proteaseH L Sham, C Zhao, K D Stewart, et al.
British Journal of Pharmacology|May 6, 2009
In vitro and in vivo characterization of A-940894: a potent histamine H4 receptor antagonist with anti-inflammatory propertiesM I Strakhova, C A Cuff, A M Manelli, et al.
Journal of Medicinal Chemistry|April 13, 2001
Discovery of inhibitors of cell adhesion molecule expression in human endothelial cells. 1. Selective inhibition of ICAM-1 and E-selectin expressionA O Stewart, P A Bhatia, C M McCarty, et al.
Journal of Medicinal Chemistry|January 23, 1998
Discovery and evaluation of a series of 3-acylindole imidazopyridine platelet-activating factor antagonistsM L Curtin, S K Davidsen, H R Heyman, et al.
Pharmacology, Biochemistry, and Behavior|May 1, 1997
Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivoC A Briggs, D J Anderson, J D Brioni, et al.
Bioorganic & Medicinal Chemistry Letters|June 20, 2001
Discovery and characterization of the potent, selective and orally bioavailable MMP inhibitor ABT-770M L Curtin, A S Florjancic, H R Heyman, et al.
Antimicrobial Agents and Chemotherapy|December 3, 1998
ABT-378, a highly potent inhibitor of the human immunodeficiency virus proteaseH L Sham, D J Kempf, A Molla, et al.
Journal of Medicinal Chemistry|August 24, 2000
3,5-Bis(trifluoromethyl)pyrazoles: a novel class of NFAT transcription factor regulatorS W Djuric, N Y BaMaung, A Basha, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Journal of Medicinal Chemistry|January 19, 1996
A novel, picomolar inhibitor of human immunodeficiency virus type 1 proteaseH L Sham, C Zhao, K D Stewart, et al.
British Journal of Pharmacology|May 6, 2009
In vitro and in vivo characterization of A-940894: a potent histamine H4 receptor antagonist with anti-inflammatory propertiesM I Strakhova, C A Cuff, A M Manelli, et al.
Journal of Medicinal Chemistry|April 13, 2001
Discovery of inhibitors of cell adhesion molecule expression in human endothelial cells. 1. Selective inhibition of ICAM-1 and E-selectin expressionA O Stewart, P A Bhatia, C M McCarty, et al.
Journal of Medicinal Chemistry|January 23, 1998
Discovery and evaluation of a series of 3-acylindole imidazopyridine platelet-activating factor antagonistsM L Curtin, S K Davidsen, H R Heyman, et al.
Pharmacology, Biochemistry, and Behavior|May 1, 1997
Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivoC A Briggs, D J Anderson, J D Brioni, et al.
Bioorganic & Medicinal Chemistry Letters|June 20, 2001
Discovery and characterization of the potent, selective and orally bioavailable MMP inhibitor ABT-770M L Curtin, A S Florjancic, H R Heyman, et al.
Antimicrobial Agents and Chemotherapy|December 3, 1998
ABT-378, a highly potent inhibitor of the human immunodeficiency virus proteaseH L Sham, D J Kempf, A Molla, et al.
Journal of Medicinal Chemistry|August 24, 2000
3,5-Bis(trifluoromethyl)pyrazoles: a novel class of NFAT transcription factor regulatorS W Djuric, N Y BaMaung, A Basha, et al.
Pageof 5